How Do I Locate the FAQs in the Calibrate App? | Calibrate

How to Find the FAQ Section in the Calibrate App

The FAQ section lives inside the Help or Support area of the Calibrate app, accessible from the bottom navigation bar or the profile menu. Tap your profile icon (usually in the lower-right or upper-right corner), scroll to "Help" or "Support," then tap "FAQ." The questions are grouped by category, covering topics like medication, billing, coaching, and scheduling.

Step-by-Step Navigation for iOS

1. Open the Calibrate app on your iPhone.
2. Tap the profile icon in the bottom-right corner of the screen.
3. Scroll down and tap "Help & Support" or "Support."
4. Tap "FAQ" or "Frequently Asked Questions."
5. Select a category (Medication, Billing, Coaching, Lab Results, etc.) to expand the questions.

If the app has updated its interface since your last login, look for a question mark icon or a "Help" label anywhere in the navigation bar. Calibrate occasionally reorganizes menus with software updates, so the exact label may shift slightly.

Step-by-Step Navigation for Android

The Android layout mirrors the iOS flow. Tap the hamburger menu (three horizontal lines) or your profile avatar at the top of the home screen. Select "Help," then "FAQ." Android users running older versions of the app may see a "Resources" tab instead. Updating to the latest version from the Google Play Store resolves most navigation discrepancies.

When the FAQ Does Not Have Your Answer

If you cannot find an answer in the FAQ, the same Support menu contains a "Contact Us" or "Message My Care Team" option. Type your question directly into the chat window. Calibrate's medical and coaching team typically responds within one business day. For urgent medication concerns, your care team can escalate to a prescribing physician.

What Is the Calibrate Program and Why Does the App Matter?

Calibrate is a telehealth metabolic-reset program built around GLP-1 receptor agonist medications, one-on-one coaching, and a structured behavioral curriculum. The app is the single interface where members manage prescriptions, attend coaching sessions, log food and activity, view lab results, and access educational content. Understanding the app layout is not optional; the program is fully digital, so navigation competence directly affects treatment outcomes.

GLP-1 Medications Prescribed Through Calibrate

Calibrate physicians most commonly prescribe semaglutide (brand name Wegovy, 2.4 mg subcutaneous weekly) for eligible members. In the landmark STEP-1 trial (N=1,961), participants receiving semaglutide 2.4 mg achieved a mean body weight reduction of 14.9% at 68 weeks, compared with 2.4% in the placebo group (P<0.001) [1]. That scale of weight reduction was not seen with lifestyle intervention alone in the same study period.

Tirzepatide (Zepbound), a dual GIP/GLP-1 receptor agonist, may also be prescribed where clinically appropriate. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg produced a mean weight reduction of 20.9% at 72 weeks versus 3.1% with placebo [2]. Both medications require ongoing physician oversight, which Calibrate delivers through the app's telehealth visit system.

Behavioral Coaching Inside the App

GLP-1 medications are substantially more effective when paired with behavioral support. A 2021 meta-analysis in Obesity Reviews (k=28 RCTs) found that adding structured behavioral intervention to pharmacotherapy produced 3.2 kg greater weight loss than pharmacotherapy alone [3]. Calibrate operationalizes this by embedding video coaching sessions, weekly check-ins, and a four-pillar curriculum (food, sleep, exercise, emotional health) directly inside the app.

The FAQ section covers common coaching questions, including how to reschedule sessions, what to do if a coach is unavailable, and how to switch coaches if the relationship is not working.

Understanding Calibrate's Four-Pillar Curriculum

Calibrate organizes its behavioral program around four domains: food quality, sleep optimization, physical activity, and emotional health. Each pillar has dedicated curriculum modules accessible from the app's home feed. The FAQ section includes a category for each pillar.

Food Quality and Metabolic Health

Calibrate's food guidance is anchored in whole-food, low-glycemic principles rather than calorie counting alone. Chronic hyperglycemia and insulin resistance are central drivers of metabolic dysfunction. The American Diabetes Association's 2024 Standards of Care note that reducing dietary refined carbohydrates improves glycemic control independent of total caloric intake [4]. Members can find food-specific FAQ answers under the "Food" category in the app.

Sleep and Hormonal Regulation

Poor sleep elevates ghrelin and suppresses leptin, increasing appetite and reducing the satiety effect of GLP-1 medications. A study published in Annals of Internal Medicine (N=10) found that sleep-restricted participants lost 55% less fat mass during caloric restriction compared with adequately sleeping controls [5]. Calibrate's sleep curriculum addresses this directly, and the FAQ covers common questions about sleep-tracking integrations.

Physical Activity Targets

The 2018 Physical Activity Guidelines for Americans recommend at least 150 minutes per week of moderate-intensity aerobic activity for adults [6]. Calibrate sets activity targets consistent with these guidelines. The app's FAQ section explains how to log workouts, sync wearable devices, and adjust targets based on physician input.

Emotional Health and Stress Management

Chronic psychological stress elevates cortisol, which promotes visceral fat accumulation and blunts insulin sensitivity [7]. Calibrate incorporates stress-reduction modules into its curriculum. FAQ entries under "Emotional Health" explain how to access these modules and what to expect from the mindset-focused coaching sessions.

How Lab Work Connects to Your Calibrate App Experience

Calibrate requires members to complete baseline and follow-up lab panels. Results appear directly in the app once processed by the partner laboratory. The FAQ section has a dedicated "Lab Results" category that explains reference ranges, what each biomarker means, and when to expect results after a blood draw.

Key Biomarkers Calibrate Tracks

Standard panels typically include fasting glucose, HbA1c, fasting insulin, lipid panel, thyroid-stimulating hormone (TSH), and a comprehensive metabolic panel. Elevated HbA1c above 5.7% indicates prediabetes; above 6.5% indicates diabetes by CDC criteria [8]. Calibrate physicians review these values before prescribing and at follow-up visits.

Interpreting Results Through the App

The app displays results with color-coded flags (normal, borderline, abnormal) and brief explanatory text. If a result is abnormal, the care team sends a follow-up message automatically. The FAQ explains what each flag color means and what action, if any, the member should take. For values outside the safe prescribing range, the prescribing physician contacts the member directly through the app's messaging system.

Medication Management Features in the Calibrate App

The app's medication section tracks dosing schedules, injection logs, and side-effect reports. GLP-1 receptor agonists require dose titration over several weeks to minimize gastrointestinal side effects. FDA prescribing information for semaglutide 2.4 mg specifies a four-step titration starting at 0.25 mg weekly for the first four weeks, escalating to the maintenance dose of 2.4 mg over 16 to 20 weeks [9].

Logging Injections and Side Effects

Members log each injection date and any side effects directly in the app. This creates a record the prescribing physician reviews at each telehealth visit. Common side effects of semaglutide include nausea (reported in 44% of participants in STEP-1), diarrhea (30%), and vomiting (24%) [1]. The FAQ section under "Medication" explains which side effects are expected during titration and which warrant immediate contact with the care team.

Prescription Renewals and Pharmacy Coordination

Calibrate coordinates with specialty pharmacies for GLP-1 prescriptions. The FAQ explains how to check prescription status, what to do if a shipment is delayed, and how to request a pharmacy transfer. Members in states where compounded semaglutide was previously dispensed should check the FAQ and care team messages for updates following FDA enforcement actions on compounded GLP-1 products [10].

Dose Escalation Questions

The FAQ covers dose escalation timing in detail. If a member experiences persistent nausea above grade 2 severity, the FAQ instructs them to message the care team before escalating to the next dose tier. This aligns with clinical guidance from the Obesity Medicine Association, which recommends individualized titration based on tolerability rather than strict calendar adherence [11].

Telehealth Visits and Coaching Sessions: Scheduling Through the App

All telehealth physician visits and coaching appointments are booked inside the Calibrate app. The scheduling interface appears under the "Appointments" or "Sessions" tab. The FAQ explains how far in advance appointments can be booked, cancellation policies, and what to do if a provider is not available within the needed timeframe.

What Happens During a Physician Visit

Physician visits cover prescription review, lab result discussion, side effect management, and dose adjustments. The American Association of Clinical Endocrinology (AACE) 2022 guidelines on obesity management recommend physician follow-up within four to eight weeks of initiating pharmacotherapy to assess tolerability and response [12]. Calibrate's visit cadence is structured to meet this recommendation.

Coaching Session Content

Coaching sessions address behavioral goals across the four pillars. Coaches are not licensed prescribers; they focus on accountability, habit change, and curriculum delivery. The FAQ clearly delineates what coaches can and cannot advise on, directing medication questions to the physician team.

Billing, Insurance, and Membership Questions in the FAQ

The Calibrate app FAQ has an extensive billing category. Common questions cover what the membership fee includes, whether GLP-1 medications are included in the program price or billed separately, and how to submit claims to insurance for potential reimbursement.

Insurance Coverage for GLP-1 Medications

GLP-1 receptor agonist coverage varies widely by plan. As of 2024, the Centers for Medicare and Medicaid Services (CMS) do not cover Wegovy for weight loss under Medicare Part D, though coverage for cardiovascular risk reduction following the SELECT trial results may be expanding [13]. The FAQ directs members to a coverage-check tool and to their Calibrate care team for prior authorization support.

SELECT Trial Cardiovascular Data

The SELECT trial (N=17,604, mean follow-up 39.8 months) found that semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% versus placebo in adults with obesity or overweight and established cardiovascular disease but without diabetes (HR 0.80; 95% CI 0.72 to 0.90; P<0.001) [14]. This trial is reshaping how insurers classify GLP-1 medications, from lifestyle drugs to cardiovascular drugs, which may affect members' coverage options over the next several years.

Membership Cancellation Policy

The FAQ outlines cancellation terms, refund eligibility windows, and how to pause membership during medical holds. Members who need to pause due to medication shortage should check the FAQ first, as Calibrate has specific protocols for shortage-related pauses that differ from voluntary cancellation.

Troubleshooting the Calibrate App When the FAQ Is Inaccessible

If the app crashes, fails to load, or the Support menu is unresponsive, the FAQ and support team are also reachable via Calibrate's website on a desktop browser. Log in at the web portal using the same credentials as the app. Alternatively, email support is listed in the original welcome email from Calibrate at account creation.

Clearing Cache and Updating the App

Most loading failures resolve by clearing the app cache (Settings → Apps → Calibrate → Clear Cache on Android; delete and reinstall on iOS) or updating to the current version. App version mismatches account for the majority of navigation errors reported in user support tickets across telehealth platforms generally. Keeping the app updated ensures FAQ content reflects the most current program policies.

Two-Factor Authentication Issues

If login fails due to two-factor authentication errors, the FAQ under "Account" explains how to reset authenticator settings. Members who lose access to their phone number or authentication app should use the web portal to submit an account recovery request directly to Calibrate's support team.

How Calibrate Compares to Other GLP-1 Telehealth Platforms

Several telehealth platforms now offer GLP-1 prescribing with app-based support. Calibrate distinguishes itself by requiring lab work before prescribing and embedding a structured behavioral curriculum rather than offering medication alone.

A 2022 systematic review in JAMA Internal Medicine (k=36 trials, N=139,818) found that intensive lifestyle intervention combined with pharmacotherapy produced significantly greater long-term weight maintenance than pharmacotherapy alone [15]. Platforms that skip structured behavioral support may produce similar short-term results but worse weight maintenance after medication discontinuation.

The Calibrate FAQ addresses questions about what happens to weight after the program ends, including guidance on maintenance dosing and continued behavioral support.

When to Use the FAQ vs. When to Message Your Care Team

The FAQ is designed for general program questions. It is not a substitute for personalized medical advice. Use the FAQ for questions about app navigation, billing, scheduling logistics, what to expect during titration, and general curriculum content.

Message your care team directly for any of the following situations.

• Nausea or vomiting that prevents eating or drinking for more than 24 hours.
• Injection site reactions that are spreading or worsening after 48 hours.
• Blood glucose readings outside your physician's specified target range.
• Any new medication started by another provider that may interact with your GLP-1 agent.
• Symptoms that could indicate pancreatitis: severe upper abdominal pain radiating to the back, especially with vomiting. The FDA label for semaglutide notes pancreatitis as a potential serious adverse event requiring drug discontinuation [9].

The FAQ explicitly states these boundaries and routes urgent clinical concerns to the physician team rather than attempting to answer them with static content.